China Patient-derived Xenograft Model Market (2025-2031) | Trends, Companies, Share, Industry, Forecast, Competitive Landscape, Size & Revenue, Outlook, Value, Growth, Segmentation, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Patient-derived Xenograft Model Market Revenues & Volume, 2021 & 2031F

3.3 China Patient-derived Xenograft Model Market - Industry Life Cycle

3.4 China Patient-derived Xenograft Model Market - Porter's Five Forces

3.5 China Patient-derived Xenograft Model Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F

3.6 China Patient-derived Xenograft Model Market Revenues & Volume Share, By Model Type, 2021 & 2031F

3.7 China Patient-derived Xenograft Model Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Growing research and development activities in oncology and drug discovery

4.2.3 Rising prevalence of cancer and the need for more accurate preclinical models

4.3 Market Restraints

4.3.1 High cost associated with patient-derived xenograft models

4.3.2 Ethical concerns related to the use of animals in research

4.3.3 Limited awareness and adoption of patient-derived xenograft models in China

6.1 China Patient-derived Xenograft Model Market, By Tumor Type

6.1.1 Overview and Analysis

6.1.2 China Patient-derived Xenograft Model Market Revenues & Volume, By Tumor Type, 2021- 2031F

6.1.3 China Patient-derived Xenograft Model Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.4 China Patient-derived Xenograft Model Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 China Patient-derived Xenograft Model Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.6 China Patient-derived Xenograft Model Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 China Patient-derived Xenograft Model Market Revenues & Volume, By Other Cancer, 2021- 2031F

6.2 China Patient-derived Xenograft Model Market, By Model Type

6.2.1 Overview and Analysis

6.2.2 China Patient-derived Xenograft Model Market Revenues & Volume, By Mice, 2021- 2031F

6.2.3 China Patient-derived Xenograft Model Market Revenues & Volume, By Rats, 2021- 2031F

6.3 China Patient-derived Xenograft Model Market, By End-user

6.3.1 Overview and Analysis

6.3.2 China Patient-derived Xenograft Model Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F

6.3.3 China Patient-derived Xenograft Model Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

6.3.4 China Patient-derived Xenograft Model Market Revenues & Volume, By CROs & CDMOs, 2021- 2031F

7.1 China Patient-derived Xenograft Model Market Export to Major Countries

7.2 China Patient-derived Xenograft Model Market Imports from Major Countries

8.1 Average time taken to develop patient-derived xenograft models

8.2 Number of collaborations between research institutions and pharmaceutical companies for PDX model development

8.3 Percentage of accuracy in predicting clinical outcomes using PDX models.

9.1 China Patient-derived Xenograft Model Market Opportunity Assessment, By Tumor Type, 2021 & 2031F

9.2 China Patient-derived Xenograft Model Market Opportunity Assessment, By Model Type, 2021 & 2031F

9.3 China Patient-derived Xenograft Model Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 China Patient-derived Xenograft Model Market Revenue Share, By Companies, 2024

10.2 China Patient-derived Xenograft Model Market Competitive Benchmarking, By Operating and Technical Parameters